Amgen (NASDAQ: AMGN) and Cytokinetics Incorporated (Nasdaq: CYTK) announced that data from the expansion phase of COSMIC-HF (Chronic Oral Study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE